Artificial Intelligence in IVD Market, By Component (Hardware, Software and Services), By Diagnosis Type, By Modality, By Technology, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
ANV6031
|
Published Date
September 2026
|
Pages
322
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Artificial Intelligence in IVD Market size was valued at US$ 510.3 Million in 2025, expanding at a CAGR of 20.9% from 2026 to 2033.
Artificial Intelligence in IVD includes algorithms, machine-learning software, computational pathology, intelligent laboratory informatics, and AI-enabled analytical workflows to interpret or support results generated from patient specimens. In contrast to traditional IVD, where measurements are primarily based on assay chemistry and instrumentation, AI adds a computational layer that can recognize patterns, integrate multimodal data, prioritize cases, and support diagnosis. Thus, the ecosystem includes laboratory instruments, software platforms, data infrastructure, validation, implementation, and lifecycle services across pathology, molecular diagnostics, hematology, and related workflows. In 2025, the U.S. FDA approved over 1,300 AI-enabled medical devices, a testament to the regulatory maturity surrounding clinical AI technologies. This is driving the market away from stand-alone algorithms and toward integrated, clinically governed diagnostic workflows.
Artificial Intelligence in IVD Market- Market Dynamics
Convergence of Multimodal Diagnostic Data With AI-Assisted Clinical Workflows
The need to translate increasingly fragmented diagnostic information into clinical intelligence that can be used is a key market driver. Laboratory results, pathology images, genomic findings, and clinical records are rarely analyzed in isolation, causing bottlenecks in workflow that AI may alleviate through automated summarization, pattern recognition, and decision support. Roche\'s 2025 Diagnostics Day materials pointed out how computational systems can lower the manual information-processing requirements, noting a 40-50% reduction in the time to summarize oncology cases with an AI-enabled abstraction tool. This is especially true for IVD, where the diagnostic value increasingly derives from integrating assay outputs with contextual patient information rather than producing a further laboratory result. This implies an increased need for interoperable AI software, verified data pipelines, and human-supervised interpretation.
Artificial Intelligence in IVD Market- Segmentation Analysis:
The Global Artificial Intelligence in IVD Market is segmented on the basis of Component, Diagnosis Type, Modality, Technology, End User, and Region.
By component, components in AI-enabled IVD are shifting from being driven solely by the algorithm to being determined by how intelligence is embedded across the entire diagnostic workflow. Software provides algorithmic interpretation, workflow orchestration, data integration, and decision-support functionality; hardware supplies the computational and laboratory infrastructure for image acquisition, high-throughput testing, and AI-enabled processing. Where labs need validation, implementation, model maintenance, cybersecurity, interoperability, and specialist support, services become important. For example, PathAI announced in March 2025 its expansion of the AISight digital pathology platform with four new laboratory partners, demonstrating how software-led ecosystems can scale AI capabilities across multiple laboratory environments. The component structure, therefore, increasingly favors integrated platforms in which hardware, software, and ongoing services work together as a coordinated diagnostic infrastructure.
By diagnosis type, diagnostic applications differ significantly in their AI needs by diagnosis type, as the underlying evidence ranges from images and physiological signals to molecular information extracted from tissue. High-volume image analysis and automated detections have positive effects on radiology and chest and lung imaging. Quantitative interpretation of cardiovascular measurements is essential for cardiology. Pattern recognition is required in complex imaging and clinical datasets in neurology. Oncology increasingly relates pathology, biomarkers, and molecular information for precision treatment decisions. This concentration is reflected in the AI devices approved in China through June 2025: 68.8% of 154 approved AI-based medical devices were related to radiology, compared to 10.4% for cardiology. The distribution suggests that data-rich and highly structured diagnostic workflows are the strongest base for AI deployment today.
Artificial Intelligence in IVD Market- Geographical Insights
The United States is leading market because AI-enabled diagnostics are being developed in a relatively mature regulatory and clinical-technology ecosystem. In 2025, the FDA\'s work on AI lifecycle management, predetermined change control mechanisms, post-market performance considerations, and authorization of AI-enabled devices provided more clarity to developers about how to iteratively improve their software. In just the 2025 CDRH/OCE report from the FDA, there were 26 IVD authorizations, including new and expanded companion-diagnostic indications. This is especially true in the case of AI in IVD, where algorithms must be compatible with validated assays, pathology workflows, and clinical decision processes. The confluence of regulated AI development and an established companion-diagnostics environment is especially important. Thus, U.S. competition is turning more to clinically validated integration, and away from just algorithmic capability.
China is a separate growth center, with a focused development of AI devices, domestic technology suppliers, and an increasingly structured regulatory pathway. A study of approvals through June 2025 revealed 20 AI-based medical-device approvals in the first half of 2025, with radiology continuing as the most common application area. The country\'s regulatory environment is also leaning toward more explicit lifecycle management of AI-powered medical devices. The NMPA\'s 2025 measures called for more refined review requirements, including consideration of multi-disease and large-model AI applications and simplified changes where core algorithms are unchanged. In the IVD AI space, this environment benefits companies that can validate locally, work through the regulations, and plug into China\'s fast-growing diagnostic technology ecosystem more than those competing on model performance alone.
Artificial Intelligence in IVD Market- Competitive Landscape:
Competitive positioning is now based on the capacity to combine diagnostic hardware, knowledge of assays, AI algorithms, clinical validation, and laboratory workflow infrastructure. Roche and Leica Biosystems, part of Danaher, offer well-established IVD and pathology platforms, whereas companies such as PathAI and Tempus provide algorithmic and computational capabilities. Roche\'s approach to partnering in the field shows how important it is to build an ecosystem: the company announced 75 new diagnostic agreements in 2025, highlighting collaboration as a way of expanding its digital and AI capabilities. On the product side, Roche has incorporated AI into computational pathology and companion diagnostics, and Danaher\'s 2025 partnership with AstraZeneca was specifically aimed at digital and computational pathology and AI-assisted algorithms. The source of competitive advantage is therefore moving toward integrated, validated AI-diagnostic platforms that have scalable laboratory connectivity.
Recent Developments:
- In April 2025, Roche was granted FDA Breakthrough Device Designation for the VENTANA TROP2 RxDx Device. This device uses AI for pathology and helps diagnose non-small cell lung cancer. It was the first time an FDA Breakthrough Device Designation was awarded to a computational pathology companion diagnostic device.
- In June 2025, PathAI received FDA clearance for AISight Dx, a pathology platform that assists with primary diagnoses. The clearance also included a Predetermined Change Control Plan, known as PCCP, which allows PathAI to add approved updates to the platform in the future.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ARTIFICIAL INTELLIGENCE IN IVD MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Roche Diagnostics
- Abbott Laboratories
- Thermo Fisher Scientific
- Danaher Corporation (including Beckman Coulter)
- Siemens Healthineers
- Sysmex Corporation
- bioMérieux
- Becton Dickinson
- Bio-Rad Laboratories
- Shenzhen Mindray Bio-Medical
- QIAGEN
- Illumina
- Hologic
- PerkinElmer
- Others
GLOBAL ARTIFICIAL INTELLIGENCE IN IVD MARKET, BY COMPONENT- MARKET ANALYSIS, 2020 - 2033
- Hardware
- Software
- Services
GLOBAL ARTIFICIAL INTELLIGENCE IN IVD MARKET, BY DIAGNOSIS TYPE- MARKET ANALYSIS, 2020 - 2033
- Radiology
- Cardiology
- Chest and Lungs
- Neurology
- Oncology
- Others
GLOBAL ARTIFICIAL INTELLIGENCE IN IVD MARKET, BY MODALITY- MARKET ANALYSIS, 2020 - 2033
- Diagnostic Imaging
- In Vitro Diagnostics
- Others
GLOBAL ARTIFICIAL INTELLIGENCE IN IVD MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- Natural Language Processing
- Deep Learning
- Computer Vision
- Machine Learning
- Predictive Analytics
GLOBAL ARTIFICIAL INTELLIGENCE IN IVD MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Ambulatory Surgery Centers
- Hospitals
- Diagnostic Laboratories
- Others
GLOBAL ARTIFICIAL INTELLIGENCE IN IVD MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
TABLE OF CONTENT
1. Artificial Intelligence in IVD Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Artificial Intelligence in IVD Market Snippet by Component
2.1.2. Artificial Intelligence in IVD Market Snippet by Diagnosis Type
2.1.3. Artificial Intelligence in IVD Market Snippet by Modality
2.1.4. Artificial Intelligence in IVD Market Snippet by Technology
2.1.5. Artificial Intelligence in IVD Market Snippet by End User
2.1.6. Artificial Intelligence in IVD Market Snippet by Country
2.1.7. Artificial Intelligence in IVD Market Snippet by Region
2.2. Competitive Insights
3. Artificial Intelligence in IVD Key Market Trends
3.1. Artificial Intelligence in IVD Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Artificial Intelligence in IVD Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Artificial Intelligence in IVD Market Opportunities
3.4. Artificial Intelligence in IVD Market Future Trends
4. Artificial Intelligence in IVD Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Artificial Intelligence in IVD Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Artificial Intelligence in IVD Market Landscape
6.1. Artificial Intelligence in IVD Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Artificial Intelligence in IVD Market – By Component
7.1. Overview
7.1.1. Segment Share Analysis, By Component, 2025 & 2033 (%)
7.1.2. Hardware
7.1.3. Software
7.1.4. Services
8. Artificial Intelligence in IVD Market – By Diagnosis Type
8.1. Overview
8.1.1. Segment Share Analysis, By Diagnosis Type, 2025 & 2033 (%)
8.1.2. Radiology
8.1.3. Cardiology
8.1.4. Chest and Lungs
8.1.5. Neurology
8.1.6. Oncology
8.1.7. Others
9. Artificial Intelligence in IVD Market – By Modality
9.1. Overview
9.1.1. Segment Share Analysis, By Modality, 2025 & 2033 (%)
9.1.2. Diagnostic Imaging
9.1.3. In Vitro Diagnostics
9.1.4. Others
10. Artificial Intelligence in IVD Market – By Technology
10.1. Overview
10.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
10.1.2. Natural Language Processing
10.1.3. Deep Learning
10.1.4. Computer Vision
10.1.5. Machine Learning
10.1.6. Predictive Analytics
11. Artificial Intelligence in IVD Market – By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
11.1.2. Ambulatory Surgery Centers
11.1.3. Hospitals
11.1.4. Diagnostic Laboratories
11.1.5. Others
12. Artificial Intelligence in IVD Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
12.2. North America
12.2.1. Overview
12.2.2. Artificial Intelligence in IVD Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.2.4. North America Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.2.5. North America Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.2.6. North America Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.2.7. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Artificial Intelligence in IVD Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.18. Denmark
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.18.3. Denmark Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.18.4. Denmark Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.3.18.5. Denmark Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.3.18.6. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.18.7. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.19. Rest of Europe
12.3.19.1. Overview
12.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.19.3. Rest of the Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.19.4. Rest of the Europe Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.3.19.5. Rest of the Europe Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.3.19.6. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.19.7. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Artificial Intelligence in IVD Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.17. Taiwan
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.17.3. Taiwan Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.17.4. Taiwan Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.4.17.5. Taiwan Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.4.17.6. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.17.7. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.18. Vietnam
12.4.18.1. Overview
12.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.18.3. Vietnam Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.18.4. Vietnam Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.4.18.5. Vietnam Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.4.18.6. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.18.7. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.19. Rest of APAC
12.4.19.1. Overview
12.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.19.3. Rest of APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.19.4. Rest of APAC Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.4.19.5. Rest of APAC Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.4.19.6. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.19.7. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Artificial Intelligence in IVD Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.8. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Artificial Intelligence in IVD Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.15. Iran
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.15.3. Iran Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.6.15.4. Iran Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.6.15.5. Iran Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.6.15.6. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.15.7. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.16. Qatar
12.6.16.1. Overview
12.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.16.3. Qatar Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.6.16.4. Qatar Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.6.16.5. Qatar Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.6.16.6. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.16.7. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.17. Rest of MEA
12.6.17.1. Overview
12.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.17.3. Rest of MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.6.17.4. Rest of MEA Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
12.6.17.5. Rest of MEA Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
12.6.17.6. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.17.7. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13. Key Vendor Analysis- Artificial Intelligence in IVD Industry
13.1. Competitive Benchmarking
13.1.1. Competitive Dashboard
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. Roche Diagnostics
13.2.2. Abbott Laboratories
13.2.3. Thermo Fisher Scientific
13.2.4. Danaher Corporation (including Beckman Coulter)
13.2.5. Siemens Healthineers
13.2.6. Sysmex Corporation
13.2.7. bioMérieux
13.2.8. Becton Dickinson
13.2.9. Bio-Rad Laboratories
13.2.10. Shenzhen Mindray Bio-Medical
13.2.11. QIAGEN
13.2.12. Illumina
13.2.13. Hologic
13.2.14. PerkinElmer
13.2.15. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ARTIFICIAL INTELLIGENCE IN IVD MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Roche Diagnostics
- Abbott Laboratories
- Thermo Fisher Scientific
- Danaher Corporation (including Beckman Coulter)
- Siemens Healthineers
- Sysmex Corporation
- bioMérieux
- Becton Dickinson
- Bio-Rad Laboratories
- Shenzhen Mindray Bio-Medical
- QIAGEN
- Illumina
- Hologic
- PerkinElmer
- Others
GLOBAL ARTIFICIAL INTELLIGENCE IN IVD MARKET, BY COMPONENT- MARKET ANALYSIS, 2020 - 2033
- Hardware
- Software
- Services
GLOBAL ARTIFICIAL INTELLIGENCE IN IVD MARKET, BY DIAGNOSIS TYPE- MARKET ANALYSIS, 2020 - 2033
- Radiology
- Cardiology
- Chest and Lungs
- Neurology
- Oncology
- Others
GLOBAL ARTIFICIAL INTELLIGENCE IN IVD MARKET, BY MODALITY- MARKET ANALYSIS, 2020 - 2033
- Diagnostic Imaging
- In Vitro Diagnostics
- Others
GLOBAL ARTIFICIAL INTELLIGENCE IN IVD MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- Natural Language Processing
- Deep Learning
- Computer Vision
- Machine Learning
- Predictive Analytics
GLOBAL ARTIFICIAL INTELLIGENCE IN IVD MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Ambulatory Surgery Centers
- Hospitals
- Diagnostic Laboratories
- Others
GLOBAL ARTIFICIAL INTELLIGENCE IN IVD MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
